Why is Incyte Corp. ?
- OPERATING CASH FLOW(Y) Highest at USD 1,002.9 MM
- ROCE(HY) Highest at 24.3%
- RAW MATERIAL COST(Y) Fallen by -1.15% (YoY)
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 43.57%, its profits have fallen by -93.3%
How much should you buy?
- Overall Portfolio exposure to Incyte Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Incyte Corp. for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 1,002.9 MM
Highest at 24.3%
Fallen by -1.15% (YoY
Highest at 5.8 times
Highest at USD 1,215.53 MM
Highest at USD 333.74 MM
Highest at 27.46 %
Highest at USD 342.67 MM
Highest at USD 248.71 MM
Highest at USD 2.04
Lowest at 4.27 times
Here's what is working for Incyte Corp.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Incyte Corp.
Inventory Turnover Ratio






